Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

33.92
Delayed Data
As of Apr 28
 +0.06 / +0.18%
Today’s Change
29.83
Today|||52-Week Range
37.39
+4.43%
Year-to-Date
French back at polls, US pharma results, Fed sets interest rates
Apr 30 / FT.com - Paid Partner Content
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
Apr 24 / Zacks.com - Paid Partner Content
Vertex (VRTX) Q1 Earnings Top, CF Products Sales Strong
Apr 28 / Zacks.com - Paid Partner Content
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies
Apr 20 / Zacks.com - Paid Partner Content
Should You Buy Pfizer (PFE) Ahead of Earnings?
Apr 28 / Zacks.com - Paid Partner Content
Is J&J's Pharma Sales Slowdown a Warning for Other Players?
Apr 19 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Lilly, Bristol-Myers, Novartis Q1 Earnings & More
Apr 28 / Zacks.com - Paid Partner Content
Lackluster J&J Q1 Pushes Healthcare ETFs Down
Apr 19 / Zacks.com - Paid Partner Content
What Happened The Last Time Companies Got A Tax-Break On Overseas Cash?
Apr 27 / Investing Channel - Paid Partner Content
Why Is Pfizer (PFE) Up 8.7% Since the Last Earnings Report?
Apr 19 / Zacks.com - Paid Partner Content
AstraZeneca's pivot point might not come until 2018
Apr 27 / FT.com - Paid Partner Content
Investors bet on Incyte drug success
Apr 19 / FT.com - Paid Partner Content
Healthy M&A Expected Following Trump's First 100 Days
Apr 27 / TheStreet.com - Paid Partner Content
Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion
Apr 18 / Zacks.com - Paid Partner Content
Clarkston Capital Partners LLC Buys Anheuser-Busch InBev SA/NV, Pfizer, T. ...
Apr 27 / GuruFocus News - Paid Partner Content
J&J (JNJ) Q1 Earnings Beat Estimates, Pharma Sales Slow Down
Apr 18 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Beats on Q1 Earnings, Ups 2017 View
Apr 27 / Zacks.com - Paid Partner Content
Did Pharma & Biotech M&As Pick Pace in Q1?
Apr 18 / Zacks.com - Paid Partner Content
Nikko Asset Management Americas, Inc. Buys Suncor Energy, Schlumberger, SRC Energy, S...
Apr 26 / GuruFocus News - Paid Partner Content
Roche's Hemophilia A Drug Positive in Second Phase III Study
Apr 17 / Zacks.com - Paid Partner Content
Hamlin Capital Management, LLC Buys Exxon Mobil, American Eagle Outfitters, First Ame...
Apr 26 / GuruFocus News - Paid Partner Content
5 Drug Stocks That Could Be Big Winners this Earnings Season
Apr 17 / Zacks.com - Paid Partner Content
Pfizer (PFE) Q1 Earnings: Will it Pull Off a Surprise?
Apr 26 / Zacks.com - Paid Partner Content
O'Reilly's top advertiser -- a gold company -- is staying
Apr 06 / CNNMoney.com
Meet The Real Emmanuel Macron: Consummate Banker Puppet, Bizarre Elitist Creation
Apr 25 / Investing Channel - Paid Partner Content
Fox News faces fresh financial and legal pressure
Apr 04 / FT.com - Paid Partner Content
Will Fresenius' $4.75 Billion Deal for Highly Coveted Akorn Spark a Bidding War?
Apr 25 / TheStreet.com - Paid Partner Content
Merck's Keytruda cancer drug records sales surge
Apr 03 / FT.com - Paid Partner Content